Increased glucose tolerance and reduced adiposity in the abscence of fasting hypoglycemia in mice with liver-specific Gsα deficiency

Journal of Clinical Investigation

Volumn 115, Issue 11, 2005, Pages 3217-3227

  Chen, Min ^a   Gavrilova, Oksana ^a   Zhao, Wei Qin ^b,c   Nguyen, Annie ^a   Lorenzo, Javier ^a,d   Shen, Laura ^a,e   Nackers, Lisa ^a   Pack, Stephanie ^a   Jou, William ^a   Weinstein, Lee S ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Blanchette Rockefeller Neurosciences Institute   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CORTICOSTERONE; CREATININE; CYCLIC AMP; FATTY ACID; GENOMIC DNA; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLYCOGEN; INSULIN; NORADRENALIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TRIACYLGLYCEROL; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL HYPERPLASIA; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY EXPENDITURE; ENVIRONMENTAL TEMPERATURE; FOOD INTAKE; GENE EXPRESSION; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE TOLERANCE; GLYCOGEN LIVER LEVEL; HYPOGLYCEMIA; HYPOINSULINEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPID METABOLISM; LIPID OXIDATION; LIPOGENESIS; LIVER WEIGHT; LOXP SITE; MALE; METABOLIC RATE; MOUSE; MOUSE STRAIN; NONHUMAN; OBESITY; PANCREAS ISLET ALPHA CELL; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SURVIVAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSITY; ANIMALS; EATING; FASTING; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HYPOGLYCEMIA; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; OXYGEN CONSUMPTION; SIGNAL TRANSDUCTION;

EID: 27644581888     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI24196     Document Type: Article

References (45)

1. DeFronzo, R.A. 1997. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 5:177-269.
2. Reaven, G.M., Chen, Y.D., Golay, A., Swislocki, A.L., and Jaspan, J.B. 1987. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 64:106-110.
3. Liang, Y., et al. 2004. Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. Diabetes. 53:410-417.
4. Parker, J.C., Andrews, K.M., Allen, M.R., Stock, J.L., and McNeish, J.D. 2002. Glycemic control in mice with targeted disruption of the glucagon receptor gene. Biochem. Biophys. Res. Comm. 290:839-843.
5. Gelling, R.W., et al. 2003. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 100:1438-1443.
6. Sloop, K.W., et al. 2004. Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. J. Clin. Invest. 113:1571-1581. doi:10.1172/JCI200420911.
7. Jelinek, L.J., et al. 1993. Expression cloning and signaling properties of the rat glucagon receptor. Science. 259:1614-1616.
8. Weinstein, L.S., Yu, S., Warner, D.R., and Liu, J. 2001. Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting. Endocr. Rev. 22:675-705.
9. Montminy, M. 1997. Transcriptional regulation by cyclic AMP. Annu. Rev. Biochem. 66:807-822.
10. Wakelam, M.J.O., Murphy, G.J., Hruby, V.J., and Houslay, M.D. 1986. Activation of two signal transduction systems in hepatocytes by glucagon. Nature. 328:68-71.
11. sα gene. Proc. Natl. Acad. Sci. U. S. A. 95:8715-8720.
12. sα knockout mice. J. Biol. Chem. 276:19994-19998.
13. Yu, S., et al. 2000. Paternal versus maternal transmission of a stimulatory G protein α subunit knockout produces opposite effects on energy metabolism. J. Clin. Invest. 105:615-623.
14. Chen, M., et al. 2004. Increased insulin sensitivity in paternal Gnas knockout mice is associated with increased lipid clearance. Endocrinology. 145:4094-4102.
15. Weinstein, L.S., Liu, J., Sakamoto, A., Xie, T., and Chen, M. 2004. Minireview: GNAS: normal and abnormal functions. Endocrinology. 145:5459-5464.
16. Chen, M., et al. 2005. Alternative Gnas gene products have opposite effects on glucose and lipid metabolism. Proc. Natl. Acad. Sci. U. S. A. 102:7386-7391.
17. Yakar, S., et al. 1999. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. U. S. A. 96:7324-7329.
18. Jhala, U.S., et al. 2003. cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2. Genes Dev. 17:1575-1580.
19. Puigserver, P., and Spiegelman, B.M. 2003. Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24:78-90.
20. Hetzig, S., et al. 2001. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature. 413:179-183.
21. Rhee, J., et al. 2003. Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): requirement for hepatocyte nuclear factor 4aα in gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 100:4012-4017.
22. Puigserver, P., et al. 2003. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction. Nature. 423:550-555.
23. Herzig, S., et al. 2003. CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ. Nature. 426:190-193.
24. Koo, S.H., et al. 2004. PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. Nat. Med. 10:530-534.
25. Foretz, M., Guichard, C., Ferre, P., and Foufelle, F. 1999. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. U. S. A. 96:12737-12742.
26. Kim, J.B., et al. 1998. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J. Clin. Invest. 101:1-9.
27. Gerich, J.E., Meyer, C., Woerle, H.J., and Stumvoll, M. 2001. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care. 24:382-391.
28. Seoane, J., et al. 1997. Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in hepatocytes. J. Biol. Chem. 272:26972-26977.
29. Trinh, K.Y., O'Doherty, R.M., Anderson, P., Lange, A.J., and Newgard, C.B. 1998. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats J. Biol Chem. 273:1615-1620.
30. Preitner, F., et al. 2004. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J. Clin. Invest. 113:635-645. doi:10.1172/JCI200420518.
31. Gonzalez, G.A., and Montminy, M.R. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 59:675-680.
32. Yoon, J.C., et al. 2001. Control of hepatic gluconeogenesis through the transcripcional coactivator PGC-1. Nature. 413:131-138.
33. Nakae, J., et al. 2002. Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 32:245-253.
34. Sun, Y., et al. 2002. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J. Biol. Chem. 277:23301-23307.
35. Valera, A., Pujol, A., Pelegrin, M., and Bosch, F. 1994. Transgenic mice overexpressing phosphoenol-pyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 91:9151-9154.
36. She, P., et al. 2003. Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation. Diabetes. 52:1649-1654.
37. Brunet, A., et al. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:857-868.
38. Yamamoto, T., et al. 2004. SREBP-1 interacts with hepatic nuclear factor-4α and interferes with PGC-1 recruitment Co suppress hepatic gluconeogenic genes J. Biol. Chem. 279:12027-12035.
39. Stumvoll, M., et al. 1998. Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am. J. Physiol. 274:E817-E826.
40. Louet, J.F., Hayhurst, G., Gonzalez, F.J., Girard, J., and Decaux, J.F. 2002. The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4α and cAMP-response element-binding protein (CREB). J. Biol. Chem. 277:37991-38000.
41. Sul, H.S., and Wang, D. 1998. Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu. Rev. Nutr. 18:331-351.
42. Webb, G.C., Akbar, M.S., Zhao, C., Swift, H.H., and Steiner, D.F. 2002. Glucagon replacement via micro-osmotic pump corrects hypoglycemia and α-cell hyperplasia in prohormone convertase 2 knockout mice. Diabetes. 51:398-405.
43. Xu, X., et al. 2001. Direct removal in the mouse of a floxed neo gene from a three-lox P conditional knockout allele by two novel approaches. Genesis. 30:1-6.
44. Eisenhofer, G., et al. 1986. Simultaneous liquid-chromatographic determination of 3,4-dihydroxy-phenylglycol, catecholamines, and 3,4-dihydroxy-phenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin. Chem. 32:2030-2033.
45. Gavrilova, O., et al. 2003. Liver peroxisome proliferator-activated receptor α contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem. 278:34268-34276.